Precision for Value Adds Prominent Health Economist Dr. Christopher Blanchette to its Expanding HEOR Team
NEW YORK, July 8, 2015 – Precision for Value (www.precisionforvalue.com), a Precision for Medicine Company which provides health economics, analytics, and marketing communications services to life sciences clients, today announced the further expansion of its Health Economics and Outcomes Research (HEOR) team to meet growing customer demand. Christopher Blanchette, PhD, was appointed Vice President, Health Economics.
Precision’s Goldman Elected to ISPOR Board of Directors
Precision’s Dana Goldman has been elected to ISPOR’s Board of Directors, effective July 1st, 2015. The Board of Directors are elected by ISPOR members – over 9,500 global members were given the opportunity to vote for nominated candidates.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is the world’s largest professional organization focused on pharmacoeconomics and outcomes research. Its total membership exceeds 16,500 from 120 countries worldwide.
Penny-Wise, Pound-Foolish Approach May Up Costs in Diabetes – Medscape Medical
Analysis from Medicare claims data from Precision’s Research Economist Joanna MacEwan, PhD at the American Diabetes Association 2015 Scientific Sessions.
By Miriam E. Tucker
BOSTON — Among US Medicare beneficiaries with type 2 diabetes, out-of-pocket expenses diminish adherence to medication and may end up increasing overall healthcare costs in the long run, a new study finds.
Fewer Than Half Of Managed Care Execs Have Access to Health-Record Data They Value – Pharmaceutical Commerce
Precision Advisors is cited in a Pharmaceutical Commerce article focusing on access to EHR data.
Specialty Services for Life Sciences Clients – CEOCFO Magazine
Recently, Dan Renick, Co-President and Chief Commercial Officer, Precision for Medicine spoke with CEOCFO Magazine on the Future of Precision Medicine. Below is an excerpt from the article: